Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure (Q43807471)

27 November 2017

Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure (English)

1 reference

27 November 2017

1 reference

congestive heart failure

1 reference

8

Martin Borggrefe

1 reference

27 November 2017

2

Martina Brueckmann

1 reference

27 November 2017

9

Ursula Hoffmann

1 reference

27 November 2017

1

Michael Behnes

1 reference

27 November 2017

3

Siegfried Lang

1 reference

27 November 2017

Florian Espeter

4

1 reference

27 November 2017

Christel Weiss

series ordinal

5

1 reference

27 November 2017

Michael Neumaier

series ordinal

6

1 reference

27 November 2017

Parviz Ahmad-Nejad

series ordinal

7

1 reference

27 November 2017

12 July 2013

1 reference

European Journal of Heart Failure

27 November 2017

1 reference

27 November 2017

15

1 reference

27 November 2017

12

1 reference

27 November 2017

1390-1400

1 reference

Controversies in ventricular remodelling

27 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Vascular calcification: pathobiological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Myocardial osteopontin expression is associated with left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Myocardial osteopontin expression coincides with the development of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Recommendations for the evaluation of left ventricular diastolic function by echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Osteopontin in cardiovascular disease: a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Increased myocardial expression of osteopontin in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Role of osteopontin in heart failure associated with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

Comments on ‘Integrated discrimination and net reclassification improvements—Practical advice’

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT112

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFT112

1 reference

27 November 2017

1 reference